Pharmacologic evaluation of shivering management in neurologically injured patients utilizing therapeutic normothermia

Uncontrolled shivering may have negative consequences by increasing metabolic demand and subsequently neutralize the benefits of therapeutic normothermia [1]. Previous anti-shivering protocols that utilize the least sedation have been described in therapeutic temperature modulation (TTM) [2]. Our aim is to describe and evaluate an anti-shivering protocol that emphasizes the least sedating regimen with the least number of pharmacologic agents for patients undergoing therapeutic normothermia.